The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adicet Bio, Inc. Common Stock 007002108 590,592 968,183 SH SOLE 968,183 0 0
Adverum Biotechnologies, Inc. Common Stock 00773U207 388,954 180,909 SH SOLE 180,909 0 0
Alnylam Pharmaceuticals, Inc. Common Stock 02043Q107 1,449,289,070 4,444,445 SH SOLE 4,444,445 0 0
Intellia Therapeutics, Inc. Common Stock 45826J105 34,734,093 3,702,995 SH SOLE 3,702,995 0 0